• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

片剂溶出受药物与崩解剂之间水分介导的固态相互作用影响。

Tablet dissolution affected by a moisture mediated solid-state interaction between drug and disintegrant.

作者信息

Rohrs B R, Thamann T J, Gao P, Stelzer D J, Bergren M S, Chao R S

机构信息

Pharmaceutical Development, Pharmacia & Upjohn, Kalamazoo, Michigan 49001, USA.

出版信息

Pharm Res. 1999 Dec;16(12):1850-6. doi: 10.1023/a:1018951309506.

DOI:10.1023/a:1018951309506
PMID:10644073
Abstract

PURPOSE

To investigate the cause for decrease in delavirdine mesylate 200 mg tablet dissolution upon exposure to high humidity.

METHODS

Dissolution testing was performed using the USP 2 (paddle) apparatus. Water in tablets was measured by Karl Fischer titration. 13C CP/MAS NMR was used to identify and quantify delavirdine form changes in tablets. FT-IR spectroscopy was used to monitor delavirdine form change in tablets and component mixes, and to investigate a solid state reaction with the disintegrant.

RESULTS

Dissolution extent of delavirdine mesylate 200 mg tablets was substantially decreased after exposure to high humidity. This effect is related to the amount of water present in the tablet matrix. 13C CP/ MAS NMR detected about 30% conversion from the mesylate salt of delavirdine to its free base form in the tablet matrix. FT-IR spectroscopy demonstrated that a solid state reaction occurs between the freed methanesulfonic acid and the carboxyl sites on the croscarmellose sodium disintegrant.

CONCLUSIONS

Water is thought to act as both a reaction medium and a plasticizer for croscarmellose sodium, facilitating protonation of the carboxyl sites on the disintegrant. This reaction has the potential to occur for any acid salt of a free base. The limiting solubility of delavirdine free base formed in the tablets accounts for much of the decrease in the extent of dissolution. A change in inter-particle bonding can explain the reduction in tablet deaggregation during dissolution.

摘要

目的

研究甲磺酸地拉韦定200mg片剂在高湿度条件下溶出度降低的原因。

方法

采用美国药典2(桨法)装置进行溶出度测试。通过卡尔费休滴定法测定片剂中的水分。采用13C CP/MAS NMR鉴定并定量片剂中甲磺酸地拉韦定的晶型变化。利用傅里叶变换红外光谱法监测片剂及组分混合物中甲磺酸地拉韦定的晶型变化,并研究其与崩解剂的固态反应。

结果

甲磺酸地拉韦定200mg片剂在高湿度条件下暴露后,溶出度显著降低。这种影响与片剂基质中存在的水量有关。13C CP/MAS NMR检测到片剂基质中甲磺酸地拉韦定的甲磺酸盐约有30%转化为其游离碱形式。傅里叶变换红外光谱法表明,游离的甲磺酸与交联羧甲基纤维素钠崩解剂上的羧基位点之间发生了固态反应。

结论

水被认为既是反应介质,又是交联羧甲基纤维素钠的增塑剂,促进了崩解剂上羧基位点的质子化。这种反应可能发生在任何游离碱的酸盐上。片剂中形成的甲磺酸地拉韦定游离碱的极限溶解度是溶出度降低的主要原因。颗粒间结合的变化可以解释溶出过程中片剂崩解的减少。

相似文献

1
Tablet dissolution affected by a moisture mediated solid-state interaction between drug and disintegrant.片剂溶出受药物与崩解剂之间水分介导的固态相互作用影响。
Pharm Res. 1999 Dec;16(12):1850-6. doi: 10.1023/a:1018951309506.
2
Incompatibility of croscarmellose sodium with alkaline excipients in a tablet formulation.羧甲淀粉钠与片剂配方中碱性赋形剂的不相容性。
Pharm Dev Technol. 2014 May;19(3):285-9. doi: 10.3109/10837450.2013.778869. Epub 2013 Mar 26.
3
IDENTIFICATION OF PHARMACEUTICAL EXCIPIENT BEHAVIOR OF CHICKPEA (CICER ARIETINUM) STARCH IN GLICLAZIDE IMMEDIATE RELEASE TABLETS.在格列齐特速释片中鹰嘴豆(Cicer arietinum)淀粉作为药用辅料的特性鉴定
Acta Pol Pharm. 2016 Mar-Apr;73(2):469-78.
4
Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.采用质量源于设计方法通过热熔挤出制备无定形固体分散体片剂配方的研究
AAPS PharmSciTech. 2016 Feb;17(1):214-32. doi: 10.1208/s12249-015-0472-0. Epub 2016 Jan 12.
5
Effect of disintegrants with different hygroscopicity on dissolution of Norfloxacin/Pharmatose DCL 11 tablets.不同吸湿性崩解剂对诺氟沙星/Pharmatose DCL 11片溶出度的影响
Int J Pharm. 2001 Mar 23;216(1-2):127-35. doi: 10.1016/s0378-5173(01)00584-1.
6
Influence of dissolution media pH and USP1 basket speed on erosion and disintegration characteristics of immediate release metformin hydrochloride tablets.溶出介质pH值和美国药典1篮法转速对速释型盐酸二甲双胍片的溶蚀和崩解特性的影响
Pharm Dev Technol. 2015;20(5):540-5. doi: 10.3109/10837450.2014.892132. Epub 2014 Mar 12.
7
The use of inorganic salts to improve the dissolution characteristics of tablets containing Soluplus®-based solid dispersions.使用无机盐改善基于 Soluplus®的固体分散体的片剂的溶解特性。
Eur J Pharm Sci. 2013 Mar 12;48(4-5):758-66. doi: 10.1016/j.ejps.2013.01.004. Epub 2013 Jan 21.
8
Effect of the mode of croscarmellose sodium incorporation on tablet dissolution and friability.交联羧甲基纤维素钠加入方式对片剂溶出度和脆碎度的影响。
J Pharm Sci. 1990 Jan;79(1):43-7. doi: 10.1002/jps.2600790111.
9
In situ determination of delavirdine mesylate particle size in solid oral dosage forms.固体口服制剂中甲磺酸地拉韦啶粒径的原位测定。
Pharm Res. 1999 Apr;16(4):545-8. doi: 10.1023/a:1018875130152.
10
Effect of tablet solubility and hygroscopicity on disintegrant efficiency in direct compression tablets in terms of dissolution.就溶出度而言,片剂溶解度和吸湿性对直接压片崩解剂效率的影响。
J Pharm Sci. 1987 Dec;76(12):907-9. doi: 10.1002/jps.2600761213.

引用本文的文献

1
Analysis of the Dissolution Behavior of Theophylline and Its Cocrystal Using ATR-FTIR Spectroscopic Imaging.使用衰减全反射傅里叶变换红外光谱成像技术分析茶碱及其共晶的溶解行为。
Mol Pharm. 2024 Jul 1;21(7):3233-3239. doi: 10.1021/acs.molpharmaceut.4c00002. Epub 2024 May 28.
2
Beyond Karl Fischer titration: a monolithic quantum cascade sensor for monitoring residual water concentration in solvents.超越卡尔·费歇尔滴定法:一种用于监测溶剂中残留水分浓度的整体式量子级联传感器。
Lab Chip. 2023 Mar 28;23(7):1816-1824. doi: 10.1039/d2lc00724j.
3
Crystalline Forms of Trazodone Dihydrates.

本文引用的文献

1
Polymorphism in anhydrous theophylline--implications on the dissolution rate of theophylline tablets.无水茶碱的多态性——对茶碱片剂溶出速率的影响
J Pharm Sci. 1997 Nov;86(11):1256-63. doi: 10.1021/js9701418.
2
How does residual water affect the solid-state degradation of drugs in the amorphous state?
J Pharm Sci. 1996 Nov;85(11):1137-41. doi: 10.1021/js960257o.
3
Solid phases of delavirdine mesylate.甲磺酸地拉韦啶的固相
J Pharm Sci. 1996 Aug;85(8):834-41. doi: 10.1021/js9600078.
曲唑酮二水合物的晶体形式。
Molecules. 2021 Sep 3;26(17):5361. doi: 10.3390/molecules26175361.
4
Effect of Formulation and Process Parameters on the Disproportionation of Indomethacin Sodium in Buffered Lyophilized Formulations.制剂和工艺参数对缓冲冷冻干燥制剂中吲哚美辛钠歧化的影响。
Pharm Res. 2018 Jan 5;35(1):21. doi: 10.1007/s11095-017-2310-4.
5
Salt Stability - The Effect of pHmax on Salt to Free Base Conversion.盐稳定性——最大pH值对盐向游离碱转化的影响。
Pharm Res. 2015 Sep;32(9):3110-8. doi: 10.1007/s11095-015-1691-5. Epub 2015 Apr 15.
6
Salt stability--effect of particle size, relative humidity, temperature and composition on salt to free base conversion.盐稳定性——粒径、相对湿度、温度及组成对盐向游离碱转化的影响
Pharm Res. 2015 Feb;32(2):549-61. doi: 10.1007/s11095-014-1484-2. Epub 2014 Aug 22.
7
Bisoprolol and bisoprolol-valsartan compatibility studied by differential scanning calorimetry, nuclear magnetic resonance and X-ray powder diffractometry.通过差示扫描量热法、核磁共振和X射线粉末衍射法研究比索洛尔与比索洛尔 - 缬沙坦的相容性。
Pharm Res. 2015 Feb;32(2):414-29. doi: 10.1007/s11095-014-1471-7. Epub 2014 Aug 13.
8
Terahertz pulsed imaging and magnetic resonance imaging as tools to probe formulation stability.太赫兹脉冲成像和磁共振成像作为探测制剂稳定性的工具。
Pharmaceutics. 2013 Oct 25;5(4):591-608. doi: 10.3390/pharmaceutics5040591.
9
Formulating weakly basic HCl salts: relative ability of common excipients to induce disproportionation and the unique deleterious effects of magnesium stearate.弱碱性 HCl 盐的成盐:常见辅料诱导非均相分解的相对能力和硬脂酸镁的独特有害作用。
Pharm Res. 2013 Jun;30(6):1628-41. doi: 10.1007/s11095-013-1002-y. Epub 2013 Mar 20.
10
Implementing quality by design in pharmaceutical salt selection: a modeling approach to understanding disproportionation.通过设计实现药物盐的质量:理解歧化的建模方法。
Pharm Res. 2013 Jan;30(1):203-17. doi: 10.1007/s11095-012-0863-9. Epub 2012 Aug 24.
4
Determination of the composition of delavirdine mesylate polymorph and pseudopolymorph mixtures using 13C CP/MAS NMR.使用13C CP/MAS NMR测定甲磺酸地拉韦啶多晶型物和假多晶型物混合物的组成
Pharm Res. 1996 Jul;13(7):1095-104. doi: 10.1023/a:1016027212156.
5
Current perspectives on the dissolution stability of solid oral dosage forms.固体口服制剂溶出稳定性的当前观点
J Pharm Sci. 1993 Feb;82(2):113-26. doi: 10.1002/jps.2600820202.
6
The dissolution and bioavailability of etodolac from capsules exposed to conditions of high relative humidity and temperatures.依托度酸在暴露于高相对湿度和温度条件下的胶囊中的溶出度和生物利用度。
Pharm Res. 1993 Sep;10(9):1295-300. doi: 10.1023/a:1018913628568.
7
Cross-linking of gelatin capsules and its relevance to their in vitro-in vivo performance.明胶胶囊的交联及其与体外-体内性能的相关性。
J Pharm Sci. 1994 Jul;83(7):915-21. doi: 10.1002/jps.2600830702.